๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tu1314 The Safety and Efficacy of Anti-Tumor Necrosis Factor-Alpha Therapy for Inflammatory Bowel Disease in Patients Post-Liver Transplantation: A Case Series

โœ Scribed by Sandhu, Amindeep S.; AlAmeel, Turki; Dale, Cheryl; Levstik, Mark; Chande, Nilesh


Book ID
122271687
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
57 KB
Volume
142
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Presentation and outcome of histoplasmos
โœ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB ๐Ÿ‘ 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection